http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
문소영(So Young Mun),김민정(Minjeong Kim) 한국언론정보학회 2016 한국언론정보학보 Vol.76 No.2
디지털 시대에 개인의 프라이버시 및 인격권 보호를 위해 잊힐 권리(the right to be forgotten)를 보장해야 한다는 주장이 꾸준히 제기되어 왔다. 본 논문은 유럽에서 촉발된 잊힐 권리에 대한 논의가 개인정보보호를 중심으로 링크 삭제 청구권이라는 법적 권리로 구체화된 반면, 한국에서 진행되고 있는 잊힐 권리 관련 논의가 언론 기사로 인한 개인의 인격권 침해 전반에 대한 피해 구제 차원으로 확대되면서 기사 삭제 청구권을 포함하는 법적 권리로 변용돼 논의되는 상황에 주목했다. 이에 본 논문은 잊힐 권리의 개념 및 그 보호법익을 해외 사례를 통해 파악한 후, 국내의 표현의 자유 규제 법률들을 살펴봄으로써 현재 추진되고 있는 기사 삭제 청구권 신설의 타당성을 검토했다. 한국은 헌법 21조 4항, 정보통신망법, 형법상의 명예훼손죄와 모욕죄, 민사상 명예훼손 손해배상 규정, 언론중재법, 공직선거법, 방송통신심의위원회의 심의, 대법원 판례 등으로 인격권과 명예훼손을 구제하는 법망이 해외에 비해 꽉 짜여 있다. 따라서 본 논문은 여기에 추가해 언론중재법에 기사 삭제 청구권을 신설하는 것은, 링크 삭제 청구권을 인정하지만 언론 기사 자체를 삭제하지는 않는 세계적 추세와 결을 달리할 뿐 아니라, 상충하는 법익들을 비교형량할 때 표현의 자유를 심대하게 침해할 위험이 크다고 주장한다. The right to be forgotten (RTBF) has been a population notion to address privacy issues associated with the digitalization of information and the dissemination of such information over the global digital network. In May 2014, the European Court of Justice (ECJ) laid down a landmark RTBF decision to grant individuals the right to be de-listed from search results. ECJ’s RTBF decision sparked an increased interest in RTBF in South Korea. Academic and non-academic commentators have provided a mistaken or outstretched interpretation of RTBF in claiming that removal of news articles should be read into RTBF in Korean law. Moreover, the Press Arbitration Commission of Korea (PAC) has proposed revising the Press Arbitration Act (PAA) to allow the alleged victims of news reporting to request the deletion of news stories. This article examines the notion of RTBF from its origin to the latest development abroad and also critically explores Korean laws regulation freedom of expression to evaluate if Korea needs the proposed PAA revision.
증례 : 소화기 ; Terlipressin 투여 후 발생한 저나트륨혈증에 의한 간질발작 1예
김진희 ( Jin Hee Kim ),김자경 ( Ja Kyung Kim ),문소영 ( So Yeong Mun ),최청조 ( Chung Jo Choi ),박한민 ( Han Min Park ),정용설 ( Yong Seol Jeong ),강준구 ( Jun Goo Kang ) 대한내과학회 2014 대한내과학회지 Vol.87 No.3
Terlipressin has splanchnic vasoconstrictive effects, and is generally used for the management of gastroesophageal variceal bleeding secondary to liver cirrhosis. Terlipressin is a synthetic arginine vasopressin (AVP) analog containing a nonapeptide sequence. Terlipressin has increased selectivity for the V1 receptor, compared with AVP; hence, it is considered to be a safe vasoconstrictor. However, side effects such as hyponatremia and seizure, although very rare, have been reported. Hyponatremia related to terlipressin may be caused by the syndrome of inappropriate antidiuresis (SIAD), which is a disorder of sodium and water balance characterized by hypotonic hyponatremia without elevation of the antidiuretic hormone level. Here, we report a case of hyponatremic seizure induced by an infusion of terlipressin in a 52-year-old female who had isolated gastric variceal bleeding secondary to alcoholic liver cirrhosis. (Korean J Med 2014;87:323-327)
TNF-α 길항제가 적응이 되는 류마티스관절염 환자들의 임상양상
손경민 ( Kyeong Min Son ),정영옥 ( Young Ok Jung ),김인제 ( In Je Kim ),김범준 ( Bum Jun Kim ),이성연 ( Seung Yun Lee ),문소영 ( So Young Mun ),서영일 ( Young Il Seo ),김현아 ( Hyun Ah Kim ) 대한류마티스학회 2013 대한류마티스학회지 Vol.20 No.6
Objective. The aim of this study was to examine clinical characteristics of Korean rheumatoid arthritis (RA) patients with clinically indications for TNF-α blocker, and to compare their clinical parameters with the Korean National Health Insurance reimbursement criteria. Methods. Data were obtained from a registry of RA patients who visited rheumatology clinics of Hallym University affiliated hospitals. Among patients who were previously prescribed DMARDs for more than three months, rheumatologists selected patients clinically indicated for TNF-a blocker. The clinical characteristics at the time TNF-α blocker use was deemed indicated were examined. Radiographic damage was quantified by Modified Sharp van der Heijde score in hand and foot simple AP radiograph. Results. From August 2010 to January 2013, five rheumatologists in four hospitals selected 109 patients clinically indicated for TNF-α blocker. When TNF-α blocker was considered, mean DAS28 was 5.2 (range 2.1∼8.05), mean swollen joint count was 6 (range 0∼22), mean tender joint count was 10.6 (range 0∼28), mean ESR was 43.2 mm/hr (range 1∼140) and mean CRP was 2.5 mg/dL (range 0.1∼18.3). The mean total modified Sharp van der Heijde score was 32.72 (range 0∼240). Eighty one percent of subjects did not have enough active joints to satisfy the Korean National Health Insurance reimbursement standard. Conclusion. Our results show that patients with clinically indications for TNF-α blocker had a broad range of disease activity and clinical parameters, and the majority did not meet the Korean National Health Insurance reimbursement criteria